TRACERx (TRAcking Cancer Evolution through therapy (Rx)) is a multi-centre, prospective cohort study that integrates clinical data with, tumour microenvironment, immunological, multi-region genomic and transcriptomic and pathologic data to develop our understanding of non-small cell lung cancer (NSCLC) evolution and identify patients who could benefit from trials of new, targeted and immunotherapy treatments.